Scripta Therapeutics

📍 Oxford, United Kingdom🗓 Founded 2025👥 19 employees💰 Last funded Mar 2025
Biotechnology Research🌐 scriptatherapeutics.com
Website LinkedIn
Scripta Therapeutics is an Oxford-based techbio company that takes a biology-first approach to discover disease-modifying drugs that modulate transcription factor activity and reprogram biology. We aim to discover and develop therapeutics for neurodegenerative disorders. We are following a unique strategy, based on the concept that transcription factors, the master controllers of gene expression, are core drivers of disease and act as detailed and dynamic maps of disease. Therapeutics that modulate these maps to restore the healthy cell state can be efficiently identified by a data-rich, lab-in-the-loop combination of experimental biology with cutting-edge AI and informatics.
3
Total investors
3
Early stage
0
Mid stage
0
Late stage
2025
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United Kingdom
2
Germany
1
Frequently asked questions
Who invested in Scripta Therapeutics?
Scripta Therapeutics has 3 investors on record on gritt.io, including 3 early-stage backers.
When did Scripta Therapeutics last raise funding?
The most recent investment in Scripta Therapeutics recorded on gritt.io was in March 2025.
When was Scripta Therapeutics founded?
Scripta Therapeutics was founded in 2025.
What industry is Scripta Therapeutics in?
Scripta Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Scripta Therapeutics based?
Scripta Therapeutics is headquartered in Oxford, United Kingdom.